Hantavirus infection natural history, complications and prognosis
Hantavirus infection Microchapters |
Patient Information |
---|
Diagnosis |
Treatment |
Case Studies |
Hantavirus infection natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Hantavirus infection natural history, complications and prognosis |
FDA on Hantavirus infection natural history, complications and prognosis |
CDC on Hantavirus infection natural history, complications and prognosis |
Hantavirus infection natural history, complications and prognosis in the news |
Blogs on Hantavirus infection natural history, complications and prognosis |
Directions to Hospitals Treating Hantavirus pulmonary syndrome |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Natural History
- Within 24 hours of initial evaluation, most patients develop some degree of hypotension and progressive evidence of pulmonary edema and hypoxia, usually requiring mechanical ventilation.
- The patients with fatal infections appear to have severe myocardial depression which can progress to sinus bradycardia with subsequent electromechanical dissociation, ventricular tachycardia or fibrillation.
- Hemodynamic compromise occurs a median of 5 days after symptom onset--usually dramatically within the first day of hospitalization.
- In contrast to HFRS, overt hemorrhage occurs rarely in HPS, although hemorrhage is occasionally seen in association with disseminated intravascular coagulation.
- If left untreated it may cause multiple organ failure and death.
Complications
Complications that can develop as a result of Hantavirus infection depends on the type of infection and can be summarized in the following table.[1]
Type of hantavirus infection | Complications |
---|---|
Hemorrhagic fever with renal syndrome (HFRS) |
|
Hantavirus cardiopulmonary syndrome (HCPS |
References
- ↑ Jiang H, Zheng X, Wang L, Du H, Wang P, Bai X (2017). "Hantavirus infection: a global zoonotic challenge". Virol Sin. 32 (1): 32–43. doi:10.1007/s12250-016-3899-x. PMID 28120221.